loading

Finanzdaten der Recursion Pharmaceuticals Inc-Aktie (RXRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
586.72%
35.54
5.175 19.22 14.74 4.546
Cost Of Revenue
2.81%
14.28
14.69 20.16 21.83 12.79
Gross Profit
323.54%
21.26
-9.512 -0.938 -7.084 -8.248
Operating Expenses
20.34%
129.60
162.69 175.29 184.28 175.52
Benefits Costs and Expenses
14.21%
143.64
167.43 191.12 217.39 183.44
Costs And Expenses
18.89%
143.87
177.38 195.45 206.11 188.31
Operating Income/Loss
37.09%
-108.33
-172.20 -176.23 -191.37 -183.77
Nonoperating Income/Loss
97.67%
0.232
9.952 4.33 -11.28 4.869
Income/Loss From Continuing Operations Before Tax
33.37%
-108.10
-162.25 -171.90 -202.65 -178.90
Income Tax Expense/Benefit
566.67%
0.02
0.003 - -0.158 0.007
Income/Loss From Continuing Operations After Tax
33.36%
-108.12
-162.25 -171.90 -202.49 -178.91
Net Income/Loss
33.36%
-108.12
-162.25 -171.90 -202.49 -178.91
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
94.45%
24.80
446.99 417.36 402.77 20.76
Diluted Average Shares
94.45%
24.80
446.99 417.36 402.77 20.76
Basic Earnings Per Share
52.78%
-0.17
-0.36 -0.41 -0.50 -0.57
Diluted Earnings Per Share
52.78%
-0.17
-0.36 -0.41 -0.50 -0.57
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):